Wells Fargo
PMD

Wells Fargo’s Psychemedics Corporation PMD Stock Holding History

Wells Fargo’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$2 – 7260
2024
Q3 		$2 Hold
1
– – ﹤0.01% 6844
2024
Q2 		$2 Sell
1
-37
-97% -$94 ﹤0.01% 6805
2024
Q1 		$111 Buy
38
+1
+3% +$3 ﹤0.01% 6630
2023
Q4 		$110 Buy
37
+2
+6% +$5 ﹤0.01% 6745
2023
Q3 		$138 Buy
35
+1
+3% +$4 ﹤0.01% 6679
2023
Q2 		$153 Buy
34
+2
+6% +$10 ﹤0.01% 6770
2023
Q1 		$173 Hold
32
– – ﹤0.01% 6812
2022
Q4 		$157 Buy
32
+2
+7% +$12 ﹤0.01% 6693
2022
Q3 		$0 Sell
30
-3
-9% -$19 ﹤0.01% 7567
2022
Q2 		$0 Buy
33
+3
+10% +$19 ﹤0.01% 7683
2022
Q1 		$0 Hold
30
– – ﹤0.01% 8018
2021
Q4 		$0 Sell
30
-257
-90% -$2.06K ﹤0.01% 7972
2021
Q3 		$2K Buy
287
+253
+744% +$1.85K ﹤0.01% 6606
2021
Q2 		$0 Hold
34
– – ﹤0.01% 7600
2021
Q1 		$0 Sell
34
-2,398
-99% -$15.9K ﹤0.01% 7524
2020
Q4 		$13K Sell
2,432
-7,572
-76% -$32.9K ﹤0.01% 5971
2020
Q3 		$44K Sell
10,004
-4,310
-30% -$21K ﹤0.01% 5554
2020
Q2 		$79K Sell
14,314
-2,431
-15% -$13.6K ﹤0.01% 5335
2020
Q1 		$101K Sell
16,745
-2,235
-12% -$18.8K ﹤0.01% 5050
2019
Q4 		$173K Sell
18,980
-5,365
-22% -$49.6K ﹤0.01% 5038
2019
Q3 		$221K Buy
24,345
+1,421
+6% +$12.1K ﹤0.01% 4902
2019
Q2 		$232K Buy
22,924
+13,398
+141% +$152K ﹤0.01% 4895
2019
Q1 		$133K Buy
9,526
+4,081
+75% +$70.2K ﹤0.01% 5025
2018
Q4 		$86K Buy
5,445
+291
+6% +$5.01K ﹤0.01% 5354
2018
Q3 		$97K Sell
5,154
-1,646
-24% -$32.8K ﹤0.01% 5372
2018
Q2 		$131K Sell
6,800
-167
-2% -$3.39K ﹤0.01% 5245
2018
Q1 		$149K Sell
6,967
-41
-0.6% -$851 ﹤0.01% 5130
2017
Q4 		$144K Buy
7,008
+4,040
+136% +$74.9K ﹤0.01% 5140
2017
Q3 		$55K Buy
2,968
+1,967
+197% +$43.3K ﹤0.01% 5437
2017
Q2 		$25K Sell
1,001
-500
-33% -$10.5K ﹤0.01% 5580
2017
Q1 		$30K Buy
+1,501
New +$33K ﹤0.01% 5616
2016
Q3 		– Sell
-1
Closed -$19 – 6383
2016
Q2 		$0 Hold
1
– – ﹤0.01% 6373
2016
Q1 		$0 Buy
+1
New +$11 ﹤0.01% 6489
2015
Q4 		– Sell
-1
Closed -$11 – 6464
2015
Q3 		$0 Sell
1
-21,441
-100% -$250K ﹤0.01% 6505
2015
Q2 		$318K Buy
21,442
+12,331
+135% +$192K ﹤0.01% 4341
2015
Q1 		$151K Buy
+9,111
New +$142K ﹤0.01% 4560
2014
Q3 		– Sell
-1,805
Closed -$25.6K – 6385
2014
Q2 		$26K Buy
1,805
+47
+3% +$714 ﹤0.01% 5263
2014
Q1 		$30K Buy
+1,758
New +$29.1K ﹤0.01% 5096
2013
Q4 		– Sell
-1
Closed -$14 – 5969
2013
Q3 		$0 Hold
1
– – ﹤0.01% 5883
2013
Q2 		$0 Buy
+1
New +$11 ﹤0.01% 5722

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
SMP
Santa Monica Partners Palm Beach Gardens, Florida $179M AUM 19.18% 1-Year Est. Return

Wells Fargo's PMD Position: Q4 2024 in Review

Wells Fargo sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 1 share — an estimated $2 sold.

Wells Fargo first reported a position in PMD in Q2 2013 and held it in 40 quarters. The position peaked at $318K in Q2 2015. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.

  • Wells Fargo reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
  • Wells Fargo sold 1 Psychemedics Corporation share in Q4 2024, an estimated $2.
  • Wells Fargo first reported a position in Psychemedics Corporation in Q2 2013 and held it in 40 quarters.
  • Wells Fargo's Psychemedics Corporation position peaked at $318K in Q2 2015.
  • 3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.

Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.